Endocrine Abstracts

Radioactive iodine (RAI) has been in use for more than 60 years with satisfactory results RAI and safe profile, there has been a different outcome of treatment in different ethnic groups. We assessed the demographic features and clinical outcome of a Jordanian and British cohorts of patients treated with RAI.Methods: Hyperthyroid patients who opted RAI as a primary therapy and those who had relapse after treatment with antithyroid drugs (ATD) or h...

Aim: To assess the impact of age, sex, duration of diabetes and body mass index confounders on diabetes control in a Jordanian cohort of T2DM at endocrine clinic at KHMC.Patients and methods: Patients randomly selected over 18 months from outpatient clinic at KHMC in Amman-Jordan. Diabetes control assessed by mean of latest 3 HbA1c and FBS. Patients were divided in 2 groups according to age (<55 years vs >55 years), gender, duration (<10 year...

Acromegaly is a chronic debilitating disease due to long term exposure to elevated levels of growth hormone (GH) which leads to excessive growth of both skeletal and soft tissues. It is slowly progressive with 30% increase in mortality rate for cardiovascular disease, respiratory complications and malignancies. The estimated prevalence of the disease is 40 cases per million with 3–4 new cases per million populations per year. Acromegaly most commonly presents between the ...

Radioactive iodine treatment for thyrotoxicosis had been introduced since 1940(s). The association of thyroid cancer and radioactive iodine (RAI131) treatment for thyrotoxicosis is rare. Rate of thyroid cancer in Jordan is 3 per 100 000 (according to Jordan National Registry).The latest population is estimated to be 5.6 million in 2006.Aim: To look for rate of thyroid cancer in a cohort of patients who received RAI131 and to report ...